The chemotherapy of rodent malaria XLI. Causal prophylaxis. Part V. Effect of mefloquine on exoerythrocytic schizogony in Plasmodium yoelii yoelii.
Previous studies using mefloquine in rodents have suggested that this compound has no effect on pre-erythrocytic schizogony. In the present study, direct observations on 46-hour-old pre-erythrocytic schizonts of P. yoelii in the liver of rats have shown that mefloquine does induce recognizable changes in the peripheral, enzyme-containing vesicles but that these are insufficient to hinder the maturation of the parasites, thus confirming that this compound has no causal prophylactic value.
D000818:Animals; D008099:Liver / Q000473:pathology / Q000648:ultrastructure; D008288:Malaria / Q000188:drug therapy* / Q000469:parasitology; D015767:Mefloquine; D010967:Plasmodium yoelii / Q000187:drug effects* / Q000648:ultrastructure; D011804:Quinolines / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains
D011804:Quinolines; D015767:Mefloquine